♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              097 Optimal Timing for Cessation of GLP-1 Agonist Before Elective Total Hip and Knee Arthroplasty

              Author:Shivan Chokshi  Nuanqiu Hou, MS  Marcus Ford, MD,FAAOS  John Crockarell, MD, FAAOS  James Guyton, MD,FAAOS  William Mihalko, MD,PhD,FAAOS  Christopher Holland, MD,MS  

              Event Title:(097-104) VIPER: Adult Reconstruction Knee I Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Monday, March 10  

              120 A High Percentage of Healthy Volunteers Fail to Pass Criteria-Based Return to Sport Testing for Arthroscopic Bankart Repair

              Author:Amit Momaya, MD,FAAOS  Mathew Hargreaves, BS  Audria Wood  John Manfredi, BS  Eugene Brabston, MD,FAAOS  Aaron Casp, MD  Thomas Evely, DO  Kevin Wilk, DPT,PT  Michael Bagwell, DPT  

              Event Title:(113-120) VIPER: Shoulder and Elbow II Papers  

              Event Type:Paper Presentations  

              Category-Classification:Shoulder and Elbow  

              Event Day:Monday, March 10  

              137 Smaller Width Quadriceps Tendon Grafts Maintain Advantageous Biomechanical Properties

              Author:Richard Lee, MD  Steven Voinier  Conor McCarthy, MD  Donald Colantonio, MD  Shawn Gee, MD, FAAOS  Christopher Tucker, MD, FAAOS  Melvin Helgeson, MD, FAAOS  Nicholas Lopreiato, MD, FAAOS  

              Event Title:(129-137) VIPER: Sports Medicine II Papers  

              Event Type:Paper Presentations  

              Category-Classification:Sports Medicine  

              Event Day:Monday, March 10  

              150 What is the Safest and Most Effective Dose of IV Dexamethasone in TKA? A Multicenter Randomized Controlled Trial

              Author:Charles Hannon, MD,MBA  Anne Debenedetti, MSc  Robert Barrack, MD,FAAOS  Young-Min Kwon, MD,PhD,FAAOS  Jess Lonner, MD,FAAOS  Rafael Sierra, MD,FAAOS  James Huddleston, MD,FAAOS  Charles Nelson, MD,FAAOS  Ran Schwarzkopf, MD,FAAOS  Gwo-Chin Lee, MD,FAAOS  Thomas Vail, MD,FAAOS  Erik Hansen, MD,FAAOS  Jeffrey Geller, MD,FAAOS  Craig Della Valle, MD,FAAOS  

              Event Title:(146-157) VIPER: Adult Reconstruction Knee II Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Tuesday, March 11  

              161 Timing of Direct Oral Anticoagulant Usage Does Not Negatively Impact Outcomes Following Hip Arthroplasty for Femoral Neck Fractures

              Author:Xiao Tony Chen, MD  Bryan Springer, MD,FAAOS  Shalmali Borkar, MBBS, MPH  Aaron Spaulding  Linjun Yang, PhD  Cody Wyles, MD  Steven Porter, MD  Joshua Bingham, MD, FAAOS  Benjamin Wilke, MD,FAAOS  

              Event Title:(158-169) VIPER: Trauma III Papers  

              Event Type:Paper Presentations  

              Category-Classification:Trauma  

              Event Day:Tuesday, March 11